Froedtert and MCW are looking for unvaccinated participants


If you are not vaccinated and you are infected with COVID-19, Froedtert & the Medical College want to hear from you.

Local infectious disease experts are currently conducting a clinical research trial to test a possible treatment option. They are studying an antiviral drug called Molnupiravir to find out if it is effective and safe for treating mild to moderate COVID-19.

“One of the reasons I’m so excited to have clinical trials is because it’s through clinical trials that we can get to the point of having other treatment options for. patients, ”said Dr. Mary Beth Graham, medical director of infection prevention and control at Froedtert and the Medical College. “If we had a drug that we could use for the virus – a pill – and keep people out of the hospital, that would be great. “

To be eligible for this clinical research trial, you must meet the following criteria:

  1. You must be at least 18 years old.
  2. You are not vaccinated.
  3. You have tested positive for COVID-19 within the past 5 days and have at least one symptom, including fever or chills, cough, shortness of breath, fatigue, muscle or body pain, new loss of taste or smell, sore throat , congestion or runny nose, vomiting or diarrhea.
  4. You have not been hospitalized due to COVID-19 and are not planning to be in hospital for the next 48 hours.
  5. To participate, you must also have a pre-existing medical condition known to increase your risk of getting serious illness from COVID-19.

The essay has already been reviewed and approved by the Institutional Review Board. It is sponsored by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (“MERCK”).

To learn more and find out if you are eligible for the clinical trial, visit

Source link

Leave A Reply

Your email address will not be published.